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Long term effects of morphine on mesangial cell proliferation
and matrix synthesis
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Long term effects of morphine on mesangial cell proliferation and
matrix synthesis. Since focal glomeruloscierosis is the predominant
glomerular lesion in heroin nephropathy and since mesangial expansion
is considered to be a precursor of giomeruloscierosis, we have evalu-
ated the effect of opiates on mesangial cell (MC) proliferation and
matrix synthesis. We showed, using a fluorometric assay, that MC are
not capable of metabolizing heroin to its active metabolite morphine.
Cells exposed to morphine (l0 M or i0 M) in prolonged cultures
either continuously (Group A) or intermittently (Group B) showed
enhanced incorporation of [3H]thymidine when compared to control
cells (control, 88600 26303 cpm/well vs. morphine iO M
-Group A,
321203 52867, P < 0.001; control vs. morphine iO- 54-Group B,
223126 46866 cpmlwell, P < 0.01; control, 107593 42284 cpm/well
vs. morphine 10 M - GroupA, 267108 41866 cpm/well, P < 0.001;
control vs. morphine lO- M - Group B, 202317 24325 cpm/well, P <
0,05). However, MC incubated with a lower concentration of morphine
(lO_6 M) enhanced DNA synthesis when exposed intermittently only
(control, 107593 42284 cpm/well vs. Group B, 219164 15552
cpmlwell, P < 0.05). This growth stimulating effect of morphine (106 M
and iO- M) was also observed at earlier time points, that is, one- and
one-and-a-half-week old cultures. However, in one-week-old cultures,
morphine in a higher concentration (l0 M) showed a suppressive
effect (P < 0.05) on MC proliferation (morphine, 3620 220 cpm/well
vs. control, 4668 410 cpmlwell). This effect not only subsided by one
and a half weeks but morphine (10—a M) treated cells enhanced MC
proliferation. An opioid antagonist, naloxone attenuated the effect of
morphine in one and half week old cultures. Morphine at 10 M to l0
M concentrations enhanced incorporation of ['H]proline in the extra-
cellular proline pool (a component of mesangial matrix) when compared
to control (control, 309661 3992 vs. morphine iO M, 363104 10539
cpm/well, P < 0.05 or morphine l0 M, 397954 31008 cpm/well, P <
0.001 or morphine 10 M, 384630 26369 cpm/well, P < 0.01). In
addition, MC incubated with morphine (l06 si and IO 54) also
enhanced (P < 0.001) synthesis of laminin. MC incubated with mor-
phine (iO M or io, 12 weeks) had a greater number of hillocks (foci
of cell proliferation and aggregated matrix) when compared with
untreated cells. Morphine treated MC synthesized a decreased amount
of PGE2 (129 48 pg/mg protein, P < 0.02) when compared to POE2
production by untreated cells (493 123 pg/mg protein). Morphine
pretreated MC when stimulated with arginine vasopressin (AVP, 10—6
M) also produced a lesser amount of PGE2 (214 51 pg/mg protein, P
< 0.05) when compared to PGE2 production by control cells under
stimulation with AVP (1393 451 pg/mg protein). Our results suggest
that morphine may be playing a direct role in mesangial expansion in
opiate addicts.
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Heroin (opiate) nephropathy is an important cause of end-
stage renal disease requiring chronic dialysis treatment [11.
Focal glomerulosclerosis has been reported to be the predom-
inant renal lesion in patients with opiate abuse [2—4]. The
mesangium is the main site of abnormality in this glomerular
lesion [4]. Since the mesangium is centrally located and the
majority of drugs which affect mesangial cells also affect other
glomerular cells, it has been difficult to study the effects of
opiates on mesangial cells (MC) in the intact glomerulus.
Because of recent developments in cell culture techniques it is
now possible to explore the mechanism of opiate-induced
mesangial injury.
We and others earlier reported that MC carry receptors for
endogenous opioids and that the ligand receptor interaction
may be linked to MC proliferation [5, 6]. Mesangial expansion
is considered to be a precursor of glomerulosclerosis [7]. Since
this expansion may be dependent either on enhanced growth of
MC or increased MC synthesis of matrix or both, we have
evaluated the effects of opiates on growth of MC and matrix
synthesis by MC. Data in our laboratory indicate that MC in
culture are not capable of metabolizing heroin to its biologically
active compound, morphine. Therefore, we have used mor-
phine instead of heroin in the present study.
Methods
Culture of glomerular MC
The culture of rat glomerular MC was carried out as previ-
ously described [8]. After three weeks in primary culture, the
MC were detached from the flask by adding a 0.25% trypsin-
EDTA solution (GIBCO, Grand Island, New York, USA) and
transferred to a plastic flask containing 5 ml of growth medium
including RPMI 1640 (GIBCO), penicillin (50 U/mI), streptomy-
cm sulfate (50 p.g/ml, GIBCO) and 10% fetal calf serum
(GIBCO). Culture flasks were kept in a 95% air-5% CO2
environment at 37°C. Subcultures were obtained within seven
to ten day intervals by the above method. The MC that were
used represent an apparently uniform cell population, as de-
tailed in previous publications from this laboratory [9—12]. MC
were seeded on 6-well, 12-well, 24-well or 96-well sterile plastic
tissue culture plates (Vangard International, Neptune, New
Jersey, USA) at a density of 5,000 cells/well. In all the experi-
ments the cells from the same primary culture were used. In
these experiments mesangial cells only from the fourth to eighth
passage were used. To have availability of mesangial cells of
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these passages only, mesangial cells of this primary culture
were frozen to provide an adequate supply. For the various
conditions in any given experiment, individual wells from the
same plate were used.
The following experimental agents were used: heroin (Na-
tional Institute of Drug Abuse, Bethesda, Maryland, USA) used
in a concentration of lO_6 morphine (NIDA) used in con-
centrations of i0 M to iO M; naloxone (Sigma Chemical
Co., St. Louis, Missouri, USA) used in a concentration of 10
ascorbic acid (Sigma) used in a concentration of 50 g/ml;
beta-aminopropionitrite (Sigma) used in a concentration of 80
g/ml; arginine vasopressin (Sigma) used in a concentration of
10—6 M); [3H]thymidine (NEN); [3H]proline (NEN); collage-
nase type VII (Sigma). Laminin (Englebreth-Holm-Swarm
Mouse Sarcoma; Sigma); rabbit anti-laminin antibody (Sigma);
rabbit peroxidase-antiperoxidase (Sigma) and anti-rabbit IgG
(Sigma).
Studies pertaining to the metabolism of heroin
Morphine is the active metabolite of heroin and has been
demonstrated to be responsible for the biological actions of
heroin [13]. Since heroin and its intermediate metabolite,
monoacetyl morphine, function largely as carriers to facilitate
access of morphine to its site of action, we have investigated
whether MC in culture have the capability of metabolizing
heroin to morphine. MC grown to confluence in 6-well plates
were washed twice and incubated with medium containing
heroin (106 M), or morphine (l06 M) or buffer alone for 24
hours (N = 3). Fluorometric assays for morphine were carried
out in the supernatants.
Fluorometric assay for morphine
A morphine fluorometric assay using the Udenfriend method
[141 was performed on cell supernatants to determine if MC
convert heroin to morphine. Briefly, cells were washed with
PBS and incubated 25 minutes with PBS alone or with heroin 1
x l0 M or morphine 1 x 106 M. The supernatants were then
dried down under vacuum. In addition to the cell supernatants
PBS not exposed to cells but containing similar concentrations
of morphine and heroin 1 x l06 M and with no agent were also
dried down. Sulfuric acid was added to each tube which was
heated at 50°C for five minutes. Five ml water and 6 ml
ammonium hydroxide were added as the tubes continued to be
heated at 50°C for two hours. The tubes were then cooled and
isobutanol added. After shaking for four minutes to extract the
fluorescence each sample was read at 420 emission and 365
excitation wavelengths on a spectrofluorometer.
Cell viability studies
Mesangial cells were plated in equal number on a 96-well
plate in incubation medium with or without morphine (106 M to
lO— M) for one and one and a half weeks duration. At the end
of the incubation period cells were removed with trypsin-
EDTA, trypan blue added, and the number of cells with and
without stain were counted in a hemocytometer. Three series of
experiments were carried out.
Determination of cellular proliferation
Prolonged culture. MC were plated in equal numbers (5000
cells/well) on 24-well sterile culture plates. Incubation medium
either alone or containing variable concentrations of morphine
(10 M to l0— M) was added to different wells and media
freshened every third day. Morphine treated cells were divided
into three groups after one week of incubation. MC in Group A
were continuously treated with morphine for the next four
weeks. MC in Group B were treated with morphine only on
alternate weeks. MC in Group C were kept without morphine
for the next four weeks. Control MC were kept in incubation
medium alone for five weeks. At the end of five weeks,
[3H]thymidine was added at 0.5 pCi per well. After a 24 hour
incubation the medium was discarded and cells were washed
gently five times. Then 0.5 ml/well of 5% trichloroacetic acid
was added. After incubation for one hour at 4°C, the supema-
tant was removed and cells were treated with 0.5 ml of 0.25 N
NaOH and kept overnight at room temperature. An aliquot was
pipetted, adjusted to pH 7,0 and radioactivity measured. Five to
seven sets of experiments were carried out for each condition
(each was carried out in triplicate). Cell proliferation was also
estimated by counting cell numbers in parallel wells treated
under identical conditions.
Short term culture. Mesangial cells were plated in equal
numbers (1500 cells/well) on a 96-well plate and incubated with
growth medium with or without morphine (106 M to iO M)
for one week. On the fifth day an aliquot of [3H]thymidine was
added to each well. After 48 hours cells were harvested by a
Skatron cell harvester and radioactivity of each well was
measured in a scintillation counter. Similarly, mesangial cells
plated on a 96-well plate was incubated with growth medium
with or without morphine (106 M to i0 M) for one and a half
weeks. On the eighth day an aliquot of [3H]thymidine was
added to each well and incorporation of [3H] as a measure of
DNA synthesis was counted after 48 hours.
Effect of naloxone on MC proliferation
We have used an opiate antagonist, naloxone, to evaluate
whether the effects of morphine on MC proliferation are linked
to opioid receptors. Mesangial cells in equal numbers were
plated on 96-well plates and incubated with growth medium
alone or growth medium + morphine (l0 M and l0 M) with
or without naloxone (106 M) for one and a half weeks. On the
eighth day an aliquot of [3H]thymidine was added to each well
and incorporation of [3H] as a measure of DNA synthesis was
counted after 48 hours.
Studies of matrix
Quantitative assessment of pro/me pool as a marker of
matrix synthesis. MC were plated in equal numbers (5000
cells/well) on 12-well plates in a low concentration so cells
could be kept long term (4 weeks) to allow for the development
of matrix. MC were incubated in RPMI medium with (10 M to
i0 M) morphine or without morphine. Once cells were very
confluent 30 pCi [3H]proline per ml was added with 50 ig/ml
ascorbic acid, 80 g/ml beta-aminopropionitrite and respective
concentrations of morphine to a 1% FCS incubation medium.
After 72 hours the supernatant was removed and the matrix
isolated by first adding 3% bovine serum albumin (BSA) and
then precipitating overnight with absolute EtOH followed by
centrifugation and washing with EtOH. The matrix was then
resuspended in 50 mrvi Tris-HCL buffer, pH 7.0 containing 1 mM
calcium chloride and 4 m N-ethyl maleimide. Ten units (per
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ml) of high purity collagenase type VII (digestive activity 1960
Jmg solid, 98% protein) was added to each sample which was
then kept in a shaking water bath at 37°C for ninety minutes [16,
171 and the non-collagen fraction re-precipitated with 20%
trichloroacetic acid before counting the supernatant in a scin-
tillation counter. An aliquot was taken from each sample for
protein measurement by the Lowry method [18]. Solubilized
cells were measured separately to determine the incorporation
of proline into the exocytosed proteins as well as intracellular
protein stores. A total of six sets of experiments were carried
out.
Evaluation of laminin production by dot blot immunoassay
(solid phase ELISA). Laminin is an important component of
mesangial matrix. The dot blot immunoassay to determine
production of laminin by morphine treated versus control cells
was performed using the method of Ayo et al [19] and Madri,
Pratt and Tucker [20]. Twenty thousand cells were plated in
each well on 6-well plates with or without varying concentra-
tions of morphine (10— 12 M to iO M) and cells were maintained
for two weeks. These confluent cells were then washed three
times in Dulbecco's PBS buffer before adding 20 mmol Tris
buffer pH 7.5 containing 2 mol/liter urea. Solubilization of cell
matrix proteins was done by scraping the cells and keeping
them on a shaker, overnight at 4°C. An aliquot was taken from
each sample for protein measurement by the Lowry method.
Samples were then vortexed and microcentrifuged to prepare
then for placement on a 0.2 m pore membrane (Hoeffer
Scientific) which was inserted in the Bio-Rad dot blot appara-
tus. The membranes had been pre-wetted in 20 mmol Tris buffer
containing 500 mmol/liter NaCl (TBS). Two hundred microliters
per sample was added to each well using vacuum filtration. In
addition, Tris-urea diluted laminin (1 ng to 100 ng) was applied
in triplicate. After rinsing wells with TBS, the membrane was
removed and rinsed with more TBS. The membrane was then
incubated for one hour, on a shaker, at room temperature in
TBS + 5% non-fat dry milk. A dilution of rabbit anti-laminin
antibody (Sigma) (1:1000) was added to TBS-5% dry milk
solution and incubation continued for one hour. The unbound
antibody was removed by washing three times with TBS.
Rabbit peroxidase-antiperoxidase (Sigma; 1:400) was added to
the TBS-milk solution and the membrane incubated for 30
minutes. Subsequently, the membrane was washed three more
times. The final incubation of the membrane was carried out by
adding anti-rabbit IgG (Sigma; 1:50) to the TBS-milk solution
and this was rinsed after 30 minutes. To develop the blot,
TBS-methanol (5:1) containing 0.15% H202 and 0.05%
4-chloro-l-naphthol (Sigma) was added and the membrane
incubated until the lowest standard became faintly visible. The
relative absorbencies were measured on an LKB 2202 ultrascan
laser densitometer and using LKB 2220 integrator a standard
curve was established and laminin concentration was deter-
mined. A total of four sets of experiments were carried out.
Morphologic evaluation of MC proliferation and aggregation
of matrix by assessing number and size of hillocks formation
Hillock formation by MC has been demonstrated to be a
result of MC proliferation and aggregation of matrix in focal
areas and has been considered to be an in vitro model of
glomerulosclerosis [15]. We therefore studied hillock formation
by morphine treated and control MC. MC were plated in 6-well
plates and kept in incubation medium containing (l0 M or
l0— M) morphine or without morphine for 12 weeks. MC were
viewed each week under an inverted microscope which has a
built in eyepiece grid containing three rectangles of small
(inner), medium (middle) and large (outer) sizes (Nikon-Dia-
phot, Japan). We categorized the size of a hillock as small if it
fitted in the small rectangle or medium if it fitted in the middle
rectangle. Two observers not aware of experimental conditions
were asked to count the number of hillocks in a given field.
Twenty consecutive fields were viewed for each variable in a
given experiment. Six sets of experiments were carried out.
Preparation of cells for scanning electron microscopic studies
Mesangial cells which were plated on glass coverslips and
incubated with growth medium with or without morphine (10-s
M) for 12 weeks, were prepared for scanning electron micro-
scopic studies using a standard technique (21). In brief, the
samples were post-fixed with 1% osmium tetraoxide (0s04)
followed by dehydration with progressive concentrations of
ethanol. These samples were then passed through critical point
dehydration, and were gold-coated prior to photography on a
JEOL JSM 25S scanning electron microscope (Tokyo, Japan).
Measurement of prostaglandin production
In our previous studies we reported that MC produce PGE2
under basal conditions and the production of POE2 was affected
by various vasoactive agents [2 1—23]. The production of PGE2
by MC plateaus at 30 minutes both under basal and stimulated
states [171. In the present study we evaluated the effect of
morphine on MC prostaglandin E2 production by using MC
from both morphine treated and vehicle (control) treated rats.
Rats were injected with either morphine (10 mg/kg) or vehicle
alone every 12 hours for 72 hours. These rats were then
sacrificed for mesangial cell culture. Cells from morphine
treated rats were continuously exposed to morphine (l0— M)
and control cells exposed to vehicle alone. Once cells were
confluent, they were replated on a 6-well plate. Confluent
control and morphine treated MC were washed gently and
incubated in I ml RPMI 1640 without calf serum at 37°C with or
without stimulant (AVP, 10—6 M) for 30 minutes, Supernatants
were aspirated and frozen immediately and stored at —20°C
until determination of PGE2. One N NaOH was added to cells to
dissolve them for Lowry protein analysis, PGE2 in each sample
was measured by radioimmunoassay and estimated (pg/mg
protein) after establishing a standard curve of known PGE2
amounts. A total of five series of experiments were carried out.
Statistical analysis
Each experimental series was carried out in triplicate with the
means of triplicate determinations serving as one experiment.
Comparisons of PGE2 production by MC under two different
conditions within each experiment were carried out by a paired
t-test. Comparison of hillock formation between untreated and
treated MC was performed by using an unpaired t-test. When
multiple groups were involved, intergroup comparisons were
performed by an analysis of variance (ANOVA). The Newman-
Keuls multiple range test was used to calculate a q value.
Differences were considered significant at P 0.05. All values
are reported as means SEM.
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Fluorescence g of protein
With cells
Without
cells
Control
Heroin (10-6 M)
Morphine (10—6 M)
8.5 2.4
10.6 0.6
69.5 2.5
12.4 1.7
10.4 0.2
51.5 17.7
MC were incubated 25 minutes with PBS alone (control) or with
heroin (10—6 M) or morphine (10—6 M). Samples from the cell superna-
tants, and PBS not exposed to cells but containing heroin (10-6 M) or
morphine (10—6 M) were extracted.
Fluorescence of each sample was read at 420 emission and 365
excitation wavelength. Results are means SEM from three sets of
experiments. These results suggest that MC do not metabolize heroin to
morphine.
Duration
of
incubation
weeks Control
Percentage of viable cells while
incubated with morphine
10-6 M i0 M iO M
1.0 83.3 1.1 82.7 11.9 91.3 8.3 85.7 9.8
1.5 82.3 9.6 89.0 11.0 83.3 1.3 84.9 7.6
Mesangial cells were plated in equal numbers onto 96-well plates and
incubated with either buffer alone (control) or buffer + morphine (10—6
M to l0 M) for 7 to 10 days. Viability of mesangial cells was evaluated
by trypan blue exclusion technique. Results are expressed as means
SEM from three series of experiments.
Fluorometric assay for morphine
Results of the fluorometric assay for morphine performed on
incubation medium with or without MC in the presence of
buffer alone or buffer + morphine (10_6 M) or buffer + heroin
(106 M) are shown in Table 1. MC incubated with buffer alone
or heroin (106 M) for 24 hours did not show any presence of
morphine in their incubation medium (N = 3). These results
indicate that MC are incapable of metabolizing heroin into its
active metabolite, morphine.
Effect of morphine on viability of mesangial cells
Viability of mesangial cells incubated with or without mor-
phine was tested by the trypan blue exclusion technique.
Percentage of viable cells in each group are shown in Table 2.
There was no difference in the percentage of viability of cells in
morphine (106 M to iO M) treated and control cells (Table 2)
at one and one and a half weeks duration. These results indicate
that morphine in concentrations 106 M to i0 M does not
affect the viability of mesangial cells.
MC proliferation studies
Prolonged culture. The effect of morphine (10_6 M to iO M)
on [3H]thymidine uptake by MC are shown in Figures 1 to 3.
MC incubated continuously with morphine (l0 M, Group A)
showed a higher (P < 0.001) incorporation of [3H]thymidine
(321203 52867 cpmlwell) when compared with untreated cells
(88600 26343 cpm/well). Similarly, MC of Group B (intermit-
tent exposure to morphine l0 M, 223126 46866 cpmlwell)
and Group C (only one week exposure to morphine, io M,
Morphine, 104M
Fig. 1. Effect of morphine (1O M) on MC proliferation. MC were
plated in equal numbers onto 24-well culture dishes and incubated with
(morphine, iO M) or without morphine. After one week MC in Group
A were continuously treated with morphine, MC in Group B treated
with morphine on alternate weeks and MC in Group C were kept
without morphine for the next 4 weeks. At the end of 5 weeks an aliquot
of [3Hthymidine (0.5 MCi) was added to each well and incorporation of
{3H]thymidine as a measure of DNA synthesis was measured after 24
hours. Results are expressed as means 5EM from seven sets of
experiments (each carried out in triplicate). Intergroup comparisons
were performed by ANOVA. A Newman-Keuls multiple range test was
performed to calculate q values. P < 0.001 control vs. Group A, P <
0.01 control vs. Group B or Group C; P < 0.05 Group A vs. Group B;
P < 0.01 Group A vs. Group C.
174797 61064 cpm/well) also showed an increase (P < 0.01) of
[3H]thymidine incorporation when compared to control cells
(88600 26303 cpm/well). Continuous exposure of MC to
morphine at iO M concentrations to MC resulted in a higher
synthesis of DNA when compared with DNA synthesis by cells
exposed intermittently (P < 0.05) or only initially (P < 0.01).
Continuous exposure of MC to morphine at iO M showed a
significantly higher (P < 0.001) incorporation of [3H]thymidine
(267108 42284 cpm/well) when compared with untreated cells
(107593 42284 cpm/well). Intermittent exposure of morphine
at 10 M also showed a higher (P < 0.05) DNA synthesis by
MC (202317 24325 cpm/well) when compared with control
(Fig. 2). However, there was no difference in DNA synthesis by
MC between Group C and control (Fig. 2). MC exposed to a
lower concentration of morphine (10_6 M) showed a higher (P <
.05) synthesis only when they were exposed to morphine
intermittently (Fig. 3, control, 107593 42284 cpmlwell, Group
B, 219448 13219 cpm/well).
The mean cell numbers were higher (P < 0.01) in Group A
cells compared to control cells (morphine lO_6 M, 164634
19297 cells/well or morphine l0 M, 129296 7341 cells/well
or morphine io M, 123538 3262 cells/well vs. control, 83253
2480 cells/well). Similar results were obtained by counting
cell numbers in parallel wells which were treated with morphine
intermittently (Table 3). These results indicate that morphine
has a growth stimulating effect on MC in prolonged culture.
Intermittent exposure of morphine even at lower concentra-
tions is stimulating.
Table 1. Fluorometric assay for morphine
P < 0.01E
a
0
4-.
Co
0
0
C)
a)C
E
>-
4-.I
C.)
4.0
3.0
2.0
1.0
0
Table 2. Effect of morphine on viability of mesangial cells
Control Group A Group B Group C
Results
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Morphine 105M
Fig. 2. Effect of morphine (10 st) on DNA synthesis by MC. Equal
numbers of MC were plated on 24-well plates and incubated with or
without morphine for 5 weeks. Morphine treated MC were divided into
three groups: Group A, continuously exposed to morphine;, Group B,
intermittently exposed to morphine and Group C, initial one week
exposure to morphine. At the end of 5 weeks, [3H]thymidine was
added, the cells harvested and radioactivity measured. Results are
means 5EM from five sets of experiments each carried out in
triplicate. Intergroup comparisons were performed by ANOVA. A
Newman-Keuls multiple range test was used to calculate q values. P C
0.001 control vs. Group A, P < 0.05 control vs. Group B; P < 0.01
Group A vs. Group C and P < 0.05 Group B vs. Group C.
Control Group A Group B Group C
Morphine 106M
Fig. 3. Effect of morphine (10 si) on [3H]thymidine incorporation by
MC, MC grown for five weeks: without morphine (control), continu-
ously exposed to morphine (Group A), intermittently exposed to
morphine (Group B) and exposed to morphine only for an initial one
week (Group C) were added an aliquot of [3Hjthymidine for 24 hours.
Cell harvesting was carried out and radioactivity measured. Results are
expressed as means SaM from five series of experiments each carried
out in triplicate. Intergroup comparisons were performed by ANOVA.
A Newman-Keuls multiple range test was used to calculate q values. P
<0.05 for Group B vs. control.
Short term cultures. The effects of morphine on mesangial
cell growth at one week and one and a half weeks are shown in
Tables 4 and 5. Mesangial cells incubated with morphine for one
Control
Morphine
10-6 M l0— M i0 M
Number of cells 118,531 156,382a l74,382a 1700026
per well
Mesangial cells were plated in equal numbers (5000 cells/well) on
24-well culture dishes and incubated with (morphine, 106 M to l0 M)
or without morphine. MC incubated with morphine were treated with
morphine only on alternate weeks. At the end of five weeks MCs were
trypsinized and cell count was carried out for each well. Results are
expressed as means SEM from five sets of experiments (each carried
out in triplicate).
a P C 0.01 morphine, 106 M or 1O M vs. control
6 P C 0.05 morphine, l0 M vs. control
Table 4. Effects of morphine on [3H]thymidine uptake by mesangial
cells at one week
Control
Morphine
l0_6 M l0— M l0- M
[3H]thymidine uptake 4668 5898k 5604' 3620
cpm/well
Mesangial cells were plated in equal numbers (1500 cells/well) on
96-well plates and incubated with buffer alone (control) or buffer
morphine (l06 M to lO M) for one week. On the fifth day an aliquot
of [3Hjthymidine was added to each well and incorporation of ll4} as a
measure of DNA synthesis was counted after 48 hours. Results are
expressed as means SaM from nine wells for each parameter.
Intergroup comparisons were performed by ANOVA. A Newman-
Keuls multiple range test was performed to calculate q vatues.
a P C 0.05 compared to control
6 P C 0.01 compared to morphine, l06 M and io M
Table 5. Effects of morphine on [3Hlthymidine uptake by mesangial
cells at one and a half weeks
Control l06 M l0 M l0 M
l3H]thymidine uptake 7264 l2223 106836 104706
cpm/well
Mesangial cells were plated in equal numbers (1500 cells/well) on
96-well plates and incubated with buffer alone or buffer + morphine
(10—6 M to l0 at) for one and a half weeks. On the eighth day an
aliquot of l3HJthymidine was added to each well and incorporation of
[3H] as a measure of DNA synthesis was counted after 48 hours.
Results are expresed as means SEM from nine wells for each
parameter. Intergroup comparisons were performed by ANOVA. A
Newman-Keuls multiple range test was performed to calculate q values.
a P C 0.01 compared to control
6 P C 0.05 compared to control
E
4.0
3.0
o 2.0a.
0
Table 3. Effect of morphine on mesangial cell proliferation
Control Group A Group B Group C
,°<0.05
4.0
3.0
2.0
1.0
0 ['1
Morphine
week at concentrations of 10—6 M (5898 330 epm/well) and
i0 M (5604 254 epm/well) show a higher (P C 0.05)
incorporation of [3H]thymidine compared to control cells (4668
410 epm/well). Whereas morphine at higher concentrations
(l0— at) show a decrease in (P < 0.05) incorporation of
[3Hlthymidine compared to control cells (Table 4). On the
contrary, cells incubated with higher concentrations of mor-
phine for one and a half weeks (Table 5) show an enhanced (P
<0.05) synthesis of DNA compared to control cells (morphine
M, 10470 549 cpm/well vs. control, 7264 586 cpml
well). Similarly, morphine also enhances (P <0.01, 10—6 M; P
cultures.
7000
0
Effects of opioid antagonist naloxone
[3H]proline incorporation studies
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5.0
3.0
0
Table 6. Extracellular [3H]proline incorporation (cpmlwell) in proline
pool
Control
Morphine
10 M 10_6 M 10 M 1O M
309661 333410 3830C,d 397954b 363104°
10539
a 11000
C0
4-
9000aI-0
C.)C
ci)C
E
>.
C N MM+N M M+NI
(106M) (105M) (104M)
Fig. 4. Effects of naloxone mesangial cell proliferation. Mesangial
cells were plated in equal number and incubated with growth medium
alone (C), growth medium + naloxone (N, 10_6 M) growth medium +
morphine (M, l0 M or iO M) growth medium + morphine (10-sM or
l0 M) + naloxone (106 M) for one and a half weeks. On the eighth
day an aliquot of [3H]thymidine was added to each well and incorpo-
ration of [3H1 as a measure of DNA synthesis was counted after 48
hours. Results are expressed as means SEM from nine wells for each
parameter. Intergroup comparisons were performed by ANOVA. A
Newman-Keuls multiple range test was performed to calculate q values.
P <0.01, control vs. morphine l0- M and iO M; P < 0.01, naloxone
(106 M) vs. morphine iO M and l0- as; P <0.05, morphine iO M
vs. morphine iO as + naloxone 10_6 M; P <0.05, morphine l0- M vs.
morphine io- as + naloxone 106 M.
<0.05, io— at) growth of MC at lower concentrations during
one and a half weeks incubation when compared to control cells
(Table 5). These results suggest that in short term cultures,
morphine in higher concentration suppresses cell growth but
this effect disappears in prolonged cultures, whereas morphine
in lower concentrations enhances cell growth even in short term
Mesangial cells were grown in 12-well culture dishes with (morphine,
iO M to l0- M) or without morphine. At the end of four weeks, 30
Ci of [3H}proline was added at 37°C. After 72 hours supernatants were
extracted and counted in a scintillation counter. Results are means
SEM from six sets of experiments (each carried out in triplicate) and are
expressed as cpm/well. Intergroup comparisons were performed by
ANOVA. A Newman-Keuls multiple range test was performed to
calculate q values.
P < 005, ' P < 0.001, C P < 0.01 compared with control
d P < 0.05 and P < 0.01 with morphine l0- M
E
a
- 4.00
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0
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0
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Fig. 5. Effect of morphine on extracellular pro/me pool as a marker of
matrix synthesis. MC were grown on 12-well culture plates with
(morphine io- M to iO M) or without (control) for four weeks. An
aliquot of [3HJproline was added to each well. After 72 hours superna-
tants were precipitated and then extracted and radioactivity measured.
Results are expressed as means SEM from six sets of experiments
each carried out in triplicate. Intergroup comparisons were performed
by ANOVA. A Newman-Keuls multiple range test was used to calcu-
late q values. P < 0.001 control vs morphine 1O M, P < 0.01 control
vs. morphine 10_6 as, P < 0.05 control vs. morphine l0- M; P <0.01
morphine io M vs. morphine iO- as, P < 0.05 morphine l0- M vs.
morphine 106 M.
intracellular protein pools (control, 9362 2731 cpmlig pro-
tein; morphine l0— M, 14658 5382 cpm//Lg protein, P < 0.02;
control vs. morphine 10 M, 21773 9903 cpm/jig protein, P
< 0.03; control vs. morphine 10—6 as, 8782 2075 cpmlp.g
protein, P < 1.0) but it did not reach a level of significance.
These results indicate that morphine enhances an extracellular
proline pool which comprises one of the important components
(collagen) of mesangial matrix.
Effect of morphine on laminin synthesis by mesangial cells
The effects of morphine (10 12 M to l0 M) on laminin
synthesis are shown in Table 7. Mesangial cells incubated with
morphine (10_6 M and l0 M) showed a higher (P < 0.001)
amount of laminin synthesis compared to control cells (mor-
phine l06 M, 10.09 0.38 ng/pg protein or morphine i04 M,
Naloxone is an opioid antagonist and widely used to reverse
the toxicity of morphine [24]. Mesangial cells incubated with
naloxone alone for one and a half weeks did not show any effect
on [3H]thymidine incorporation compared to control cells (Fig.
4). Naloxone did attenuate the stimulating effect of morphine (P
<0.05, morphine 10 at, 10683 718 cpmlwell vs. morphinel0 as naloxone 10—6 as, 8774 459 cpm/well; P < 0.05,
morphine i0 as, 10470 549 cpm/well vs. morphine l0— M +
naloxone l0_6 M, 7784 523 cpmlwell). These results indicate
that naloxone is able to inhibit the effect of morphine (l0— M
and i0 at) in short term cultures.
Extracellular incorporation of [3H]proline by MC into a
proline pool in response to variable concentrations (10 M to
i0 M) of morphine are shown in Table 6 and Figure 5.
Morphine (106 M to i0 as) enhanced [3H]proline incorpora-
tion (control, 309661 3992 cpm/well vs. lO_6 M, 384630
26369, P <0.01; l0 as, 397954 31008 cpm/well, P < 0.001;
l0 M, 363104 10539 cpmlwell, P < 0.05) by MC in the
extracellular matrix. Morphine at 1O M and l0 M concen-
trations also increased incorporation of [3H]proline into the
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Table 7. Effect of morphine on laminin synthesis (ng/g protein) by
mesangial cells
Control
Morphine
l02 M 10b0 M 10_8 M 106 M l0 M
5.51 6.72 5.34 8.98 l0.09a 1319aj
Equal number of mesangial cells (20,000 cells/well) were plated on
6-well culture dishes with (morphine, 10_12 M to l0 M) or without
morphine for two weeks. At the end of three weeks laminin synthesis in
each well was determined by dot blot immunoassay. Results are means
SEM from four sets of experiments and are expressed as ng/p.g of cell
protein. Intergroup comparisons were performed by ANOVA. A New-
man-Keuls multiple range test was performed to calcualte q values.
a P < 0.001 compared with control, morphine l02 M and 10_to Mb P < 0.05 compared to 10—8 M
13.19 0.53 ng/p.g protein vs. control, 5.51 0.51 ng/p.g
protein). These results indicate that morphine treated cells also
synthesize a higher amount of laminin.
Morphologic evaluation of MC proliferation and matrix
aggregation
Morphological studies were carried out by recording the
number and size of hillock formation by MC at 12 weeks [15].
Illustrative photographs are shown in Figures 6 and 7. MC
treated with morphine (l0— M or iO ss) had a greater number
of hillocks when compared with untreated cells as quantified by
the percentage of fields showing hillock formation (N = 6;
control 64 3% vs. morphine (l0— M), 77 4%, P < 0.05;
control vs. morphine lO M, 88 2%, P < 0.001). Effects of
morphine on the size and number of hillock formation are
shown in Table 8. Morphine treated cells formed a higher
number of both small (10 M,P < 0.001; i04M, P < 0.05) and
medium (10 M, P < 0.05; l0 M, P < 0.01) sized hillocks
when compared to untreated cells. Control MC also formed a
lesser (P < 0.02) number of large hillocks when compared to
morphine treated cells. These results indicate that morphine
enhances foci of MC proliferation and matrix aggregation as
depicted in the formation of higher number and larger sizes of
hillocks by morphine treated MC.
Scanning electron microscopic studies
Representative photographs of hillock formation by mor-
phine treated mesangial cells and untreated (control) cells are
shown in Figures 7A and 7B. Mesangial matrices beneath the
control cells and morphine treated cells are shown in Figures
8A and 8B.
PGE2 production studies
The effect of morphine on the production of PGE2 under
basal as well as stimulated states are shown in Figure 9.
Morphine treated MC synthesized a decreased (129 48 pg/mg
of protein, P < 0.02) amount of PGE2 when compared to
control (493 123 pg/mg of protein (N = 5). Morphine
pretreated MC when stimulated with AVP (10_a M) also pro-
duced a lower (214 51 pg/mg protein, P < 0.05) amount of
PGE2 in comparison with PGE2 produced by control MC
stimulated with AVP alone (1393 451 pg/mg of protein).
Fig. 6. Hillock formation by mesangial cells. A. Hillock formation by
control (untreated) cells. B. Hillock formation by morphine treated
cells. (x 140)
These results suggest that morphine decreases production of
PGE2 under basal as well as in a stimulated state.
Discussion
The present study demonstrates that morphine enhances
mesangial cell growth and matrix synthesis as judged by the
uptake of [3H]thymidine and proline, respectively. This was
further confirmed by increased number and larger sizes of
hilocks (foci of cell proliferation and matrix aggregation) for-
mation and enhanced synthesis of laminin by morphine treated
cells.
The presence of opioid receptors has been reported in the
kidneys [25]. Nevertheless exact localization of opioid recep-
tors in the kidneys has not been documented [26]. Ooi, Mac-
Carthy and Hsu provided indirect evidence of the presence of
beta-endorphin receptors on cultured mouse mesangial cells [5].
We have also recently reported that rat MC in culture express
specific beta-endorphin receptors which may be linked to the
proliferation of MC [6]. In addition to neuronal cells, receptors
for opiates have been demonstrated in two cell types important
in immune injury. These cell types are T-lymphocytes [27] and
mononuclear phagocytes [28]. This is consistent with the im-
munomodulatory role of opiates in human and animal studies.
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Fig. 7. Hillock formation by mesangial cells. A. A representative scanning electron microphotograph showing hillock formation by control
mesangial cells. Closed arrow shows aggregation of mesangial cells and matrix. Open arrow shows superconfluent mesangial cells. (X 500) B.
Electron microphotograph showing hillock formation by morphine (l0- 54) treated mesangial cells. Closed arrows show aggregated matrix and
mesangial cells. Open arrow shows superconfluent mesangial cells. (x 500)
Table 8. Number and size of hillocks in morphine treated and
untreated cells
Size of hillocks
Small Medium Large
0.89 0.15 0.42 0.07 0.13 0.06
2.06 0.12a 1.54 0.46C 0.22 0.08
1,94 0.59" 1.89 047d 1.35 o.51
Control
Morphine io— M
Morphine iO M
Mesangial cells were grown on 6-well culture dishes and were
incubated with (10-i 51 or iO M) or without morphine for 12 weeks.
MC were viewed under an inverted microscope to observe hillock
formation. After establishing an arbitrary scale of small to large
hillocks, the number of hillocks were counted in a given field. Twenty
fields were examined in each well. Results are means SEM from six
series of experiments (each carried out in triplicate).
Small hillocks: a Control vs. Morphine l0- M, P < 0.001
"Control vs. Morphine i04 s, P < 0.05
Medium hillocks: C Control vs. Morphine l0- M, P < 0.05d Control vs. Morphine iO M, P < 0.01
Large hillocks: Control vs. Morphine l0— M, P < 0.02
Preliminary data in our laboratory suggests that rat MC express
low affinity receptors for morphine (unpublished observation).
The mesangial matrix is a dynamic structure that greatly
influences the physiology of MC. MC synthesize matrix com-
ponents [29] and control how they polymerize and assemble. In
turn, the matrix dictates organization and function of the cells
[301. MC in prolonged culture produce a moderate accumula-
tion of matrix similar to that seen in the mesangium of diseased
glomeruli. Sterzel et al [15] suggested that these mesangial
nodules termed 'hillocks' provide a useful in vitro model of
glomerulosclerosis. In the present study morphine treated cells
not only formed a greater number of hillocks but also produced
hillocks of larger sizes. This is consistent with the glomerulo-
sclerotic lesion in opiate addicts. Proline uptake studies also
confirmed that morphine treated cells produced a greater incor-
poration into the proline pool when compared to the amount of
proline pool formed by untreated MC.
Morphine in higher concentrations has been demonstrated to
have a growth inhibitory effect in short term studies of fibro-
blasts [31]. This effect has been shown to disappear upon
prolonged or intermittent exposure to morphine [31]. This is
consistent with the development of tolerance to morphine in
opiate addicts. In the present study, morphine also suppressed
growth of MC only at a higher concentration (10 M) at one
week of incubation, but this suppression of morphine disap-
peared by one and a half weeks. On the contrary, morphine at
lower concentrations (10 M and 10 M) showed an increased
growth of MC on short term as well as on prolonged cultures.
Results were also pronounced even at lower concentrations of
morphine when MC were treated intermittently. Intermittent
exposure of MC to morphine is more akin to the in vivo
situation of opiate addicts because opiate addicts rarely get a
supply of heroin on a continuous basis.
Theoretically, prolongation of cell life rather than enhanced
proliferation may also increase final cell counts in morphine
:. *3w'
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Fig. 8. A glimpse of mesangial matrix as
seen under scanning electron microscope. A.
Mesangial cells and mesangial matrix under
control conditions. The arrows show
mesangial matrix underneath the untreated
mesangial cells. (x 5000) B. Mesangial cells
and mesangial matrix under morphine treated
(10—i M) condition. The arrows show
mesangial matrix underneath the morphine
treated mesangial cells. (x 5000)
treated groups. However, if morphine treated cells were also
producing higher amounts of DNA even at earlier time points.
these cells would also be likely to increase in number on the
basis of enhanced rate of DNA synthesis. Mesangial cells
incubated with morphine in concentrations 106 M and i0 M
for one week showed higher (P < 0.05) amounts of DNA
synthesis compared to control cells. Similarly, mesangial cells
incubated with morphine for one and a half weeks at concen-
trations of 10 M to 1O M also showed a higher (P < 0.01,
morphine 10 M and io; P < 0.05, morphine 10—6 M) amount
of [3Hjthymidine incorporation compared to control cells. Since
mesangial cells incubated with morphine at a concentration of
iO M showed suppression of DNA synthesis at one week but
an increase in DNA synthesis at one and a half weeks, it
appears that at higher concentrations morphine exerts suppres-
sive effects on cell growth but this effect is only temporary and
not operative in later time periods. This phenomenon perhaps
suggests a drug tolerance effect.
An alternate mechanism which also remains a theoretical
possibility is that an increased rate of cell death by a cytotoxic
effect of morphine at higher concentrations eventually gives rise
to increased cell proliferation of surviving cells (resistant to
cytotoxic effects of morphine). This is consistent with the
animal model where initial mesangiolysis is followed by mesan-
gial cell proliferation [32—34]. One of the mechanisms which has
been suggested is that initial exposure of mesangial cells to
cytotoxic agents like superoxide radicals or anti-Thy 1.1 anti-
bodies may kill the predominant cell population in the mesan-
gium and may leave behind a resistant or a stem cell population
which may proliferate subsequently. In the present study,
firstly the majority of the cells were viable at the earlier time
points. Secondly, a lower concentration of morphine (10_6 M)
produced a higher growth rate compared to MC treated with a
higher concentration of morphine (10k M) in one and a half
week old cultures. However, MC incubated with a higher
concentration of morphine (10 M) for one week did show
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Fig. 9. Effect of morphine (10 M) on PGE2
production by MC. Mesangial cells grown
from morphine treated rats and control rats
were subcultured on six-well plates with
(morphine l0- M) or without morphine.
Confluent control and morphine treated cells
were incubated with (AVP lO_6 M) or without
AVP for 30 minutes. PGE2 in each well was
measured by radioimmunoassay and estimated
(pg/mg of cell protein). A total of five sets of
experiments were carried out. A. Basal PGE2
production by control and morphine treated
cells (P < 0.02) at 30 minutes. B. PGE2
production by control MC stimulated with
AVP (10-6 M) vs. MC treated with morphine
and then stimulated with AVP (10-6 M). P <
0.05.
suppression of [3Hjthymidine incorporation compared to con-
trol cells as well as to MC treated with lower concentrations of
morphine. However this suppressive effect of morphine on the
growth of MC not only subsided by one and a half weeks, but
morphine in the same concentration also enhanced the growth
of MC as judged by DNA synthesis. This hypothesis seems to
be plausible for higher concentrations of morphine (l0— M).
However, presently, we can only infer that at higher concen-
trations morphine initially suppresses growth of mesangial
cells. Whether this effect is cell specific or not remains a
speculation.
Since morphine treated cells produce a lesser amount of
PGE2 both under basal as well as stimulated states, and PGE2
has been reported to attenuate the growth of MC as well as
production of matrix by MC [35, 36], it seems a lack of POE2 in
morphine treated cells may only be partly responsible for
enhanced growth and increased matrix production by MC.
Morphine also seems to affect MC in other ways besides via
PGE2 production because the classical lesions inflicted by
nonsteroidal anti-inflammatory agents or PGE2 inhibitors are
predominantly interstitial [37].
The effects of morphine on the reticuloendothelial system and
wandering mononuclear phagocytes suggest that opiates hinder
phagocytosis and the respiratory burst by these cells in stimu-
lated states [38, 39]. This may explain why patients with opiate
abuse suffer from frequent and serious infections and perhaps
have a more or less persistent elevated concentration of various
phlogogenic macromolecules (endotoxins, immune complexes
and other bacterial and inflammatory products) in the blood.
Since delivery of circulating macromolecules into the mesan-
gium is dependent on their serum levels, we hypothesize that
patients with opiate abuse are likely to have increased delivery
of phlogogenic macromolecules into the mesangium. In addi-
tion, our study provides a suggestion that morphine attenuates
production of POE2 by MC under basal as well as stimulated
states. This may be important as PGE2 has been shown to
suppress the inflammatory response and to prevent the progres-
sion of nephritis in experimental animals [40]. A deficient
release of PGE2 by MC in response to accumulated macromol-
ecules in the presence of morphine may enhance inflammatory
activity in the mesangium which may be damaging to the
mesangial cells as well as to the matrix, and eventually may lead
to glomerulosclerosis.
We conclude that prolonged exposure to morphine enhances
MC proliferation and matrix synthesis. The present study
provides a mechanistic insight into the role of morphine in
mesangial expansion. While our observations must be extended
they do provide a basis for understanding how glomerular
lesions develop in patients with opiate abuse.
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